Completed PHASE4 INTERVENTIONAL 2-arm NCT01369186

Drug Drug Interactions of Aspirin and P2Y12-inhibitors

Drug Drug Interactions of Antiplatelet Drugs and Morphine

Sponsor: Medical University of Vienna

Conditions Drug Interaction Potentiation Myocardial Infarction

Updated 6 times since 2017 Last updated: Mar 23, 2017 Started: May 31, 2011 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Drug Interaction Potentiation and Myocardial Infarction, this trial is completed. The trial is conducted by Medical University of Vienna and has accumulated 6 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Apr 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Apr 2017 [monthly]

Completed PHASE4

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Vienna

Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria